Annual Total Long Term Liabilities
$23.82 M
+$7.36 M+44.72%
31 December 2023
Summary:
Kiniksa Pharmaceuticals annual total long term liabilities is currently $23.82 million, with the most recent change of +$7.36 million (+44.72%) on 31 December 2023. During the last 3 years, it has risen by +$20.88 million (+710.38%). KNSA annual total long term liabilities is now -80.11% below its all-time high of $119.77 million, reached on 31 December 2017.KNSA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$22.34 M
-$705.00 K-3.06%
30 September 2024
Summary:
Kiniksa Pharmaceuticals quarterly total long term liabilities is currently $22.34 million, with the most recent change of -$705.00 thousand (-3.06%) on 30 September 2024. Over the past year, it has dropped by -$1.48 million (-6.21%). KNSA quarterly long term liabilities is now -81.35% below its all-time high of $119.77 million, reached on 31 December 2017.KNSA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -6.2% |
3 y3 years | +710.4% | +660.0% |
5 y5 years | +1759.3% | +1643.7% |
KNSA Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +710.4% | -11.4% | +660.0% |
5 y | 5 years | at high | +1759.3% | -11.4% | +4622.4% |
alltime | all time | -80.1% | >+9999.0% | -81.3% | >+9999.0% |
Kiniksa Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $22.34 M(-3.1%) |
June 2024 | - | $23.04 M(-2.2%) |
Mar 2024 | - | $23.57 M(-1.1%) |
Dec 2023 | $23.82 M(+44.7%) | $23.82 M(-2.7%) |
Sept 2023 | - | $24.47 M(-2.9%) |
June 2023 | - | $25.20 M(+55.8%) |
Mar 2023 | - | $16.18 M(-1.7%) |
Dec 2022 | $16.46 M(+460.0%) | $16.46 M(-15.4%) |
Sept 2022 | - | $19.45 M(+43.7%) |
June 2022 | - | $13.54 M(-5.8%) |
Mar 2022 | - | $14.37 M(+388.8%) |
Dec 2021 | $2.94 M | $2.94 M(-33.0%) |
Sept 2021 | - | $4.38 M(-5.5%) |
June 2021 | - | $4.64 M(-7.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $5.01 M(-11.9%) |
Dec 2020 | $5.68 M(+343.6%) | $5.68 M(+461.6%) |
Sept 2020 | - | $1.01 M(+114.0%) |
June 2020 | - | $473.00 K(-49.2%) |
Mar 2020 | - | $932.00 K(-27.2%) |
Dec 2019 | $1.28 M(+789.6%) | $1.28 M(-45.1%) |
Sept 2019 | - | $2.33 M(-15.5%) |
June 2019 | - | $2.76 M(+0.5%) |
Mar 2019 | - | $2.75 M(+1808.3%) |
Dec 2018 | $144.00 K(-99.9%) | $144.00 K(-13.8%) |
Sept 2018 | - | $167.00 K(-10.2%) |
June 2018 | - | $186.00 K(+520.0%) |
Mar 2018 | - | $30.00 K(-100.0%) |
Dec 2017 | $119.77 M(+49.9%) | $119.77 M |
Dec 2016 | $79.90 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Kiniksa Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of KNSA is $23.82 M
What is the all time high annual total long term liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual total long term liabilities is $119.77 M
What is Kiniksa Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of KNSA is $22.34 M
What is the all time high quarterly long term liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly total long term liabilities is $119.77 M
What is Kiniksa Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, KNSA quarterly total long term liabilities has changed by -$1.48 M (-6.21%)